You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table GPS-9. Lifetime prevalence (percentage) of drug use among young adults (aged 15 to 34 years old) in nationwide surveys among the general population: last survey available for each Member State

Country	Geographical area	Year	Ref.	Age range young adults	Sample size young adults	Cannabis (%)	Cocaine (%) (1)	Amphet-amines (%) (2)	Ecstasy (%) (3)	LSD (%)
Belgium	National	2004	(6)	15-34		23.7
Bulgaria	National	2005	(1)	18-34	433	8.7	2.4	2.8	2.6	1.5
Czech Republic	National	2004	(2)	18-34	1414	38.3	1.8	4.7	14.6	2.5
Denmark	National	2005	(4)	16-34	3583	49.5	9.1	12.7	5.3	2.4
Germany	National	2003	(6)	18-34	3775	36.1	5.0	5.4	5.3	3.4
Estonia	National	2003	(2)	15-34	646
Ireland	National	2002-03	(4)	15-34		24.0	4.7	4.8	7.1	4.6
Greece	National (except Aegean and Ionian Islands)	2004	(3)	15-34	2620	10.8	1.0	0.2	0.6	0.4
Spain	National	2005-06	(6)	15-34	14699	38.6	9.6	5.3	7.0
France	National	2005	(6)	15-34	10855	43.6	3.5	1.3	3.7	1.6
Italy	National	2005	(3)	15-34	16552	34.6	7.4	2.2	3.4	3.8
Cyprus	National	2006	(1)	15-34	1753	9.9	1.4	0.8	2.4	1.0
Latvia	National	2003	(1)	15-34		19.6	1.9	5.3	5.0	2.2
Lithuania	National	2004	(1)	15-34	1814	13.0	0.7	2.2	2.1	0.5
Luxembourg	National	1998	(1)	15-34		15.8	0.3		1.9	1.3
Hungary	National	2003	(2)	18-34	2319	17.4	1.5	4.5	5.6	3.1
Malta	National	2001	(1)	18-34	640	4.8	0.9	0.7	1.4	0.5
Netherlands	National	2005	(3)	15-34		32.3	4.9	3.0	8.1	1.5
Austria	National	2004	(1)	15-34	1754	28.0	2.8	3.5	4.6	1.8
Poland	National	2002	(1)	16-34		14.7	1.3	4.1	1.5	2.5
Portugal	National	2001	(1)	15-34	6406	12.4	1.3	0.6	1.4	0.6
Romania	National	2004	(1)	15-34		2.9	0.7	0.5	0.5	0.3
Slovakia	National	2004	(2)	15-34	578	28.2	1.7	2.6	7.4
Finland	National	2004	(6)	15-34	1031	22.0	2.1	4.1	3.3	1.4
Sweden	National	2006	(7)	16-34	14408	19.1
United Kingdom	England and Wales	2005-06	(9)	16-34	12329	41.5	12.1	16.8	13.3	7.6
United Kingdom	Northern Ireland	2002-03	(10)	15-34		25.1	2.9	7.2	11.4	7.8
United Kingdom	Scotland	2004	(12)	16-34	978	34.4	8.1	14.4	11.4	7.9
United Kingdom	United Kingdom	2004	(13)	16-34		42.3	11.1	17.9	13.4	9.0
Norway	National	2004	(2)	15-34	1238	25.5	4.3	5.9	3.6	1.7

Notes:

(1) Cocaine any form.

(2) For Belgium National 2001 and for Metropolitan France 1995: amphetamine and ecstasy.

(3) For Spain: ecstasy and other designer drugs.

This table aims to provide an overview of national surveys. Exceptionally, some relevant regional surveys are presented. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates, which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). Athens was included as a reference point for the 1993 survey.

In surveys with small sample sizes results should be interpreted with caution.

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups.

For methods and definitions on population surveys in general, see General population surveys of drug use – methods and definitions.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

See Table GPS-0.